How many investments has P53 Invest made?

P53 Invest has 11 tracked investments.

What stage does P53 Invest invest at?

P53 Invest invests at the Seed, Series A stages.

What sectors does P53 Invest focus on?

P53 Invest focuses on Biotech, Digital Health, Healthtech, Medical Devices.

Where is P53 Invest located?

P53 Invest is headquartered in Stavanger, NO.

Who does P53 Invest co-invest with?

P53 Invest most often shares deals with Catalio Capital Management, LP, FJ Labs, Future Ventures, among 19 tracked co-investors.

P53 Invest

Venture capital

Stavanger · Seed–Series A · 5 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

P53 Invest is a healthcare investment company that identifies and backs businesses seeking to challenge and disrupt the status quo in healthcare. Its portfolio is built around companies founded on strong science and technologies, and the firm emphasizes a long-term value creation philosophy.

Invests inBiotech Digital Health Healthtech Medical Devices Denmark Germany Norway Stavanger Switzerland

Source: firm website, verified Aug 3, 2026.

Stage

Seed–Series A

Stavanger, NO

Instruments

Equity

Founded

2018

Tracked investments

Team · 5 people

from the firm's website & public directories

Susanne Stuffers· CEO & founding partner· Delhi, Indiain

Holds an M.D. from Erasmus University Rotterdam and a Ph.D. in cancer biomedicine from the Norwegian Radiumhospital. She has broad healthcare and life sciences experience as a management consultant at EY, in medical and commercial roles at Novartis, clinical oncology practice, and as a healthcare equity analyst at Arctic Securities before co-founding and leading P53.

s•••@tdveen.noreveal

Lars Mørland Knudsen· Investment Director· Charleston, South Carolina Metropolitan Areain

Holds a master's in molecular biology from Oslo University with research at the Norwegian Radiumhospital, where he later worked for several years and contributed to published research. He worked as a healthcare equity research analyst at Arctic Securities before joining P53 Invest.

l•••@p53.noreveal

Kjell Skappel· Chair of the board

CEO of TD Veen and founding partner of Stavanger Venture AS, an angel-to-venture-phase investment company established with TD Veen in 2010. He previously served as Regional Director Europe North at Cisco Systems and held leadership roles at TANDBERG ASA prior to its acquisition by Cisco.

Øyvind Schanke· Director

Chief Investment Officer at TD Veen with an MBA from NHH and over 25 years of investment experience. He was previously CEO of Skagen Funds and spent nearly 16 years at the Norwegian Sovereign Wealth Fund, latterly as CIO for asset management in London.

Silje Veen· Director

Holds a marketing degree from the Norwegian Business School (BI) specializing in local business development. She founded and ran the food concept Food Story for over a decade and chairs the board of TD Veen.

What they invest in

from 9 of 11 portfolio companies

Biotech ×6Healthtech ×4Medical Devices ×3Deep Tech ×2Marketing Tech ×2Mental Health ×2AI & Machine Learning ×1Creator Economy ×1

HQs:Norway×4Denmark×1United Kingdom×1United States×1

Investments · 11 tracked

founders shown can be your intro path

AtaiBeckleyatai.lifeNASDAQ: ATAI

AtaiBeckley develops rapid-acting mental health treatments and therapies for patients with difficult-to-treat mental health conditions.

BiotechDeep TechDigital HealthMedical DevicesMental Health

Srinivas Rao(Co-Founder and Chief Executive Officer)Christian Angermayer(Founder and Chairman of the Board)

Co-investorsAble Partners Alpha Wave Global Catalio Capital Management, LP FJ Labs Future Ventures Leafy Tunnel +3 more

Teitur Trophicsteiturtrophics.com inMar 2023✓ verified

Teitur Trophics is a biotech company developing first-in-class cyclic peptides that target lysosomal, mitochondrial and pro-survival signaling pathways to preserve neuronal function.

BiotechDeep TechHealthtechAarhus, DK

Simon Mølgaard(Co-founder & CEO)Anders Dalby(Co-founder)Mathias Ollendorff(Co-founder)Simon Glerup(Co-founder)

Co-investorsIndustrifonden Innovestor Sound Bioventures Sunstone Capital

Aldenteal-dente.no in

Aldente is a Norwegian agency that co-creates strategy, communication, and solutions with a focus on sustainability.

Impact & Social GoodMarketing Tech

Arxx Therapeuticsarxxtx.com

Calluna Pharmacallunapharma.com in

Completed patient enrollment in its Phase 2 AURORA trial.

Co-investorsSarsia Management AS

Centenara Labscentenara.com in 𝕏

Centenara Labs is a longevity-focused drug discovery company that translates research on the biology of aging into therapies intended to improve healthy aging and extend lifespan.

BiotechHealthtechLongevity

Christian Angermayer(Founder)in

Co-investorsCatalio Capital Management, LP Korify Capital

Kodekskodeks.no in

Kodeks develops custom websites and online stores, combining design, technology, and digital strategy, and builds editor-friendly sites in collaboration with design agencies.

E-commerceMarketing TechSaaS

Nykode Therapeuticsnykode.com in

Nykode Therapeutics is a biotechnology company; this investor relations page provides shareholder information, financial reports, and corporate governance details but does not describe the company's specific products or therapeutic focus.

BiotechHealthtechMedical DevicesOslo, NO

Serenatis Bioserenatisbio.com in

Serenatis Bio develops small-molecule drugs targeting glutamate and dopamine pathways to treat obsessive-compulsive disorder, a mental health condition with limited effective therapeutic options.

BiotechMental HealthCambridge, GB

Nick Sireau(Executive Chairman & Co-founder)inDavid Cavalla(CEO & Co-founder)

Tom Hagatomhaga.no

Tom Haga is a photography and film studio offering commercial imagery across categories including hotels, branding, interiors, products, portraits, food and restaurants, aquaculture, industrial, and cars.

Creator EconomyMedia & Entertainment

Tom Haga

Valink Therapeuticsvalinktx.com in

Valink Therapeutics develops bispecific antibody-drug conjugates (ADCs) for therapeutic applications, combining high-throughput discovery, antibody engineering, and medicinal chemistry capabilities.

AI & Machine LearningBiotechHealthtechMedical DevicesBoston, US

Arne Scheu(Founder)inIrsyad Khairil(Founder)in

Co-investorsHoxton Ventures LongeVC Metaplanet Oxonian Ventures SynBioVen Y Combinator +1 more

Exits · 1

IPOs and acquisitions across the tracked portfolio

AtaiBeckleyNASDAQ: ATAI

Portfolio news

latest coverage across their companies

Cathie Wood’s ARK sells ATAI stock, buys X-Energy shares By Investing.com

AtaiBeckley · investing.com · Jul 17, 2026

Valink Therapeutics Closes $11.8M Pre-A Financing Round

Valink Therapeutics · finsmes.com · Oct 20, 2025

Frequently asked questions

How many investments has P53 Invest made?: P53 Invest has 11 tracked investments.
What stage does P53 Invest invest at?: P53 Invest invests at the Seed, Series A stages.
What sectors does P53 Invest focus on?: P53 Invest focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Where is P53 Invest located?: P53 Invest is headquartered in Stavanger, NO.
Who does P53 Invest co-invest with?: P53 Invest most often shares deals with Catalio Capital Management, LP, FJ Labs, Future Ventures, among 19 tracked co-investors.

Similar investors

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

$10M – $50M

Breyer Capital

Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.

$500K – $10M

DCVC (Data Collective)

DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.

$5M – $25M

Eight Roads Ventures

Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.

$5M – $30M

GV (Google Ventures)

GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.

$250K – $50M